Vitamin D for Painful Diabetic Neuropathy: A Systematic Review and Meta‐Analysis of Randomised Controlled Trials
Endocrinology, Diabetes & Metabolism · 2025-11 · 8 (6)
DOI: 10.1002/edm2.70118 ↗Kurz gefasst
Metaanalyse in der Zeitschrift Endocrinology, Diabetes & Metabolism, online erschienen am 26.10.2025. Verfasst von Abraham Gilbody und 1 weiteren Autor:innen. Beteiligte Einrichtung: North Bristol NHS Trust, Bristol, UK. Hauptthemen laut MEDLINE: Diabetic Neuropathies, Vitamin D, Vitamin D Deficiency, Vitamins. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Painful diabetic neuropathy ( PDN ) is a common complication of type 1 and type 2 diabetes, causing substantial morbidity. Current treatments, including antidepressants and analgesics, are often only partially effective and may have significant side effects. Vitamin D deficiency affects around 60% of people with diabetes, making supplementation a low‐toxicity, biologically plausible intervention. Observational studies suggest potential benefit, but robust evidence from randomised controlled trials ( RCTs ) is lacking.
Objective
To systematically review and synthesise RCT evidence on the effect of vitamin D supplementation on pain outcomes in PDN.
Methods
A systematic search was conducted in Medline, EMBASE , Web of Science, Cochrane Library, CINAHL , EBSCO and Google Scholar up to September 2025. Eligible studies were RCTs comparing vitamin D supplementation with placebo in adults with diabetes and PDN . The primary outcome was pain intensity measured with validated tools. A fixed‐effects meta‐analysis was performed, with results expressed as standardised mean differences ( SMD ). Risk of bias was assessed using the Cochrane RoB tool, and publication bias examined via Egger's funnel plot.
Results
Five studies met inclusion criteria; four ( n = 320) were included in the meta‐analysis. Pooled results showed a significant short‐term reduction in pain with vitamin D versus placebo ( SMD = −0.85; 95% CI: −1.07 to −0.62), with moderate heterogeneity ( I 2 = 61.4%), equivalent to ~11 points on common pain scales. No studies reported medium‐ or long‐term outcomes. Study quality varied, with concerns regarding allocation concealment and selective outcome reporting. Four trials were prospectively registered.
Conclusion
Vitamin D supplementation may reduce short‐term pain in PDN, but evidence is limited by small sample sizes and methodological quality. Larger, rigorously designed RCTs with longer follow‐up are needed before routine vitamin D testing or supplementation can be recommended for PDN in clinical practice.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- North Bristol NHS Trust, Bristol, UK.
- MRC Integrative Epidemiology Unit, University of Bristol, Bristol, UK.
ORCID-Profile: Abraham Gilbody, Joseph Gilbody
Zitieren
APA
Gilbody, A., & Gilbody, J. (2025). Vitamin D for Painful Diabetic Neuropathy: A Systematic Review and Meta‐Analysis of Randomised Controlled Trials. Endocrinology, Diabetes & Metabolism, 8(6). https://doi.org/10.1002/edm2.70118
Vancouver
Gilbody A, Gilbody J. Vitamin D for Painful Diabetic Neuropathy: A Systematic Review and Meta‐Analysis of Randomised Controlled Trials. Endocrinology, Diabetes & Metabolism. 2025;8(6). doi:10.1002/edm2.70118
BibTeX
@article{Gilbody2025,
author = {Gilbody, Abraham and Gilbody, Joseph},
title = {Vitamin D for Painful Diabetic Neuropathy: A Systematic Review and Meta‐Analysis of Randomised Controlled Trials},
journal = {Endocrinology, Diabetes & Metabolism},
year = {2025},
volume = {8},
number = {6},
doi = {10.1002/edm2.70118}
}
EUVIMED